论文部分内容阅读
《中国新药杂志》(ISSN 1003-3734,CN11-2850/R)是由国家食品药品监督管理局主管的国家级药学核心期刊,为中国科技核心期刊、中文核心期刊、“中国期刊方阵‘双效’期刊”、“《CAJ-CD规范》执行优秀期刊”。《中国新药杂志》已被《美国化学文摘》(CA)、荷兰《医学文摘》(EmBase)《国际药学文摘》等众多国际权威数据库收录;同时被中国生物医学期刊引文数据库、中国学术期刊综合评价数据库等国内权威检索数据库收录。2008年被评为中国精品科技期刊。
China National Institute of Materia Medica (ISSN 1003-3734, CN11-2850 / R) is a state-level core pharmaceutical journals under the supervision of the State Food and Drug Administration. It is one of the core journals of science and technology in China, Chinese core journals, Double effect ’periodical “, ” CAJ-CD specification “implementation outstanding periodical ”. “China New Drugs Magazine” has been included in many international authoritative databases such as “American Chemical Abstracts” (CA) and Dutch “Medical Abstracts” (“International Pharmacology Digest”). At the same time, it is evaluated by China Biomedical Journals Citation Database and Chinese Academic Journals Database and other domestic authoritative database retrieval. 2008 was named China’s high-quality scientific and technical journals.